-
Falcon confirms gene identity (LRCOL1 / ENSG00000204583 / approved name "leucine rich colipase like 1") but found no LRCOL1-specific primary literature establishing molecular function, localization, or pathway membership; the colipase-like assignment remains a domain-based inference.
"Tool searches found **no direct primary papers focused specifically on human LRCOL1/A6NCL2 molecular function**. Available evidence is mostly indirect, high-throughput, or database-integrated rather than targeted biochemical characterization"
-
Domain-based working hypothesis is lipase cofactor-like activity, consistent with existing IEA annotations for enzyme activator activity, lipid catabolic process, digestion, and extracellular region; no direct biochemical validation was retrieved.
"Because the requested UniProt entry indicates a **colipase/colipase-like domain**, the most plausible primary function is **lipase cofactor-like activity** (e.g., assisting lipid digestion or lipase function at lipid–water interfaces). This is a **bioinformatic/domain-based inference** and should be treated as unvalidated for LRCOL1 until targeted biochemical assays are reported."
-
Open Targets aggregates hypothesis-generating disease associations for LRCOL1 (hepatocellular carcinoma differential expression; neurodegenerative disease signal from a glutamatergic-neuron CRISPRi survival screen; GWAS credible-set signals for atrial fibrillation, brain aneurysm, COVID-19); association scores are small-to-modest and not mechanistic.
"Open Targets scores are **small to modest** and derive from heterogeneous evidence types; they should be interpreted as **hypothesis-generating associations**, not proof that LRCOL1 is causal or clinically actionable in these diseases"